Severe psychotic disorder and agranulocytosis--a therapeutic dilemma.
Borbé
R
R
Weisel
K
K
Sachs
U J H
UJ
Steinert
T
T
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D005500:Follow-Up Studies; D006098:Granulocytes / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D000077152:Olanzapine; D012559:Schizophrenia / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine